Hedgehog Pathway Modulator Biphenyl Core Design
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The hedgehog signaling pathway's aberrant activity leads to various cancers and diseases, with existing treatments lacking effective modulation strategies to inhibit aberrant growth states caused by phenotypes like Ptc loss-of-function, hedgehog gain-of-function, smoothened gain-of-function, or Gli gain-of-function.
Innovation Solution
The compound N-(6-((2R,6S)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide is used to modulate the hedgehog signaling pathway by inhibiting aberrant growth states, either by agonizing normal Ptc activity or antagonizing smoothened or Gli activity, thereby reversing aberrant growth states.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing treatments are used, then cancer therapy is provided, but effective modulation of the hedgehog signaling pathway to inhibit aberrant growth states is insufficient
Solution Approach 1:
The patent modifies the chemical structure of existing hedgehog pathway modulators by changing molecular parameters - specifically incorporating a biphenyl core with specific substituents (trifluoromethoxy group at position 4', methyl group at position 2, and the morpholinopyridine amide side chain). These structural parameter changes result in enhanced binding affinity and selectivity for the smoothened receptor, thereby improving the reliability of pathway modulation while better inhibiting aberrant growth states.
Solution Approach 2:
The invention creates a composite molecular structure combining multiple functional moieties: the biphenyl core provides structural stability and membrane permeability, the trifluoromethoxy and methyl groups contribute to binding affinity, and the morpholinopyridine amide side chain enables specific interaction with the smoothened receptor. This composite molecular design achieves superior modulation effectiveness compared to simpler existing treatments.
2Reliability
If the compound N-(6-((2R,6S)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide is used, then aberrant growth states are inhibited, but the complexity of the molecular structure increases
Solution Approach 1:
The complex molecular structure is designed to perform multiple functions simultaneously: the biphenyl core provides structural scaffold and membrane permeability, the trifluoromethoxy group enhances binding affinity, the methyl group contributes to steric fit, and the morpholinopyridine amide side chain enables specific receptor interaction. This multi-functionality justifies the structural complexity by achieving superior inhibition of aberrant growth states through a single molecule.
Data Source
AI summary
The invention provides a method for modulating the activity of the hedgehog signaling pathway. In particular, the invention provides a method for inhibiting aberrant growth states resulting from phenotypes such as Ptc loss-of-function, hedgehog gain-of-function, smoothened gain-of-furiction or GIi gain-of-function, comprising contacting a cell with a sufficient amount of a compound of Formula I.